Cerebrospinal Fluid Markers for Alzheimer's Disease Evaluated after Acute Ischemic Stroke
Camilla Hesse(Sahlgrenska University Hospital), Kaj Blennow(Sahlgrenska University Hospital), Hugo Vanderstichele(ADx NeuroSciences), Eugeen Vanmechelen(ADx NeuroSciences), Christer Jensen(University of Gothenburg), Pia Davidsson(AstraZeneca (South Korea)), Lars Rosengren(Sahlgrenska University Hospital)
Cited by 212
Related Papers
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
|New England Journal of Medicine|2014|2k
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria
|Alzheimer s & Dementia|2016|1.9k